Filing Impact
Filing Sentiment
Form Type
4
CEL-SCI Corp
Aug 14, 2025
[10-Q] Cel-Sci Corporation Quarterly Earnings Report
39.18M
6.72M
1.45%
3.23%
30.03%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
VIENNA